Both the knockdown of CSF‐1 or reactivation of miR‐130b expression using the DNMT inhibitor 5‐aza‐CdR were shown to sensitize drug‐resistant ovarian cancer cells to anticancer drugs.67 The gene discussed is CSF1; the disease is ovarian cancer.